Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesIllinoisRecruitingNCT00079001
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaIllinoisRecruitingNCT00132301
Prostate Cancer Utilities and Cost-Effectiveness AnalysisIllinoisRecruitingNCT00203918
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerIllinoisRecruitingNCT00309985
Lycopene in Preventing Prostate Cancer in Healthy ParticipantsIllinoisRecruitingNCT00322114
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesIllinoisRecruitingNCT00377156
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate CancerIllinoisRecruitingNCT00414388
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)IllinoisRecruitingNCT00424385
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerIllinoisRecruitingNCT00430183
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation TherapyIllinoisRecruitingNCT00450411
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate CancerIllinoisRecruitingNCT00450619
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerIllinoisRecruitingNCT00567580
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial NeoplasiaIllinoisRecruitingNCT00596011
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC PatientsIllinoisRecruitingNCT00654186
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate CancerIllinoisRecruitingNCT00668642
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate CancerIllinoisRecruitingNCT00765479
Salvage Cryotherapy in Recurrent Prostate CancerIllinoisRecruitingNCT00824928
Study of Immunotherapy to Treat Advanced Prostate CancerIllinoisRecruitingNCT00861614
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesIllinoisRecruitingNCT00874211
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After CastrationIllinoisRecruitingNCT00878436
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer PatientsIllinoisRecruitingNCT00919035
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerIllinoisRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerIllinoisRecruitingNCT00942331
TNFerade Biologic to Treat Locally Advanced Prostate CancerIllinoisNot yet recruitingNCT01048151
Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerIllinoisRecruitingNCT01057810
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerIllinoisRecruitingNCT01120236
Genistein in Treating Patients With Prostate CancerIllinoisRecruitingNCT01126879
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerIllinoisRecruitingNCT01145508
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)IllinoisRecruitingNCT01194960
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerIllinoisRecruitingNCT01212991
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerIllinoisAvailableNCT01217697
Study of Hypo-fractionated Proton Radiation for Prostate CancerIllinoisRecruitingNCT01230866
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerIllinoisRecruitingNCT01234311
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceIllinoisRecruitingNCT01238172
Bicalutamide With or Without MK2206 in Treating Patients With Previously Treated Prostate CancerIllinoisRecruitingNCT01251861
Cediranib Maleate With or Without Dasatinib in Patients With Hormone-Resistant Prostate Cancer Resistant to Treatment With DocetaxelIllinoisRecruitingNCT01260688
Saracatinib in Treating Patients With Prostate CancerIllinoisRecruitingNCT01267266
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyIllinoisRecruitingNCT01270880
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate CancerIllinoisRecruitingNCT01283373
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerIllinoisRecruitingNCT01288911
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.IllinoisRecruitingNCT01302054
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineIllinoisRecruitingNCT01302067
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerIllinoisRecruitingNCT01306890
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerIllinoisRecruitingNCT01308567
Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyIllinoisRecruitingNCT01309672
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenIllinoisRecruitingNCT01314118
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerIllinoisRecruitingNCT01342367
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerIllinoisRecruitingNCT01360840
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerIllinoisRecruitingNCT01368588
A Study to Assess Efficacy and Safety With VESIcare® to Improve Urinary Continence in Subjects After Robotic Assisted Radical ProstatectomyIllinoisRecruitingNCT01371994
Comparison of Between ThinSeedâ„¢ and OncoSeedâ„¢ for Permanent Prostate BrachytherapyIllinoisRecruitingNCT01379742
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerIllinoisRecruitingNCT01415960
An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate CancerIllinoisRecruitingNCT01478412
Hypo-fractionated Proton Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the ProstateIllinoisRecruitingNCT01492972
Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy ParticipantsIllinoisRecruitingNCT01497431
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate CancerIllinoisRecruitingNCT01543776
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsIllinoisNot yet recruitingNCT01567462
Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib on Bone Metastases in Patients With Castrate Resistant Prostate CancerIllinoisRecruitingNCT01599793
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerIllinoisRecruitingNCT00063882
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100IllinoisRecruitingNCT01605227
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyIllinoisAvailableNCT01606982